December 11, 2021
Multiplex Engineering of Human CD34+ HSPCs Enables Dual Gene Knockout While Maintaining High Engraftment Potential and Safety
CD33-CLL1 Treatment System, Platform
Presented by: Nipul Patel – Discovery and Molecular Engineering – Vor Bio
ASH – 2021 – Poster Presentation 2939